Pfizer (Germany) Analysis

Pfizer Stock Analysis Notes

About 71.0% of the company shares are owned by institutional investors. The book value of Pfizer was at this time reported as 17.03. The company has Price/Earnings To Growth (PEG) ratio of 1.19. Pfizer Inc recorded earning per share (EPS) of 5.16. The entity last dividend was issued on the 26th of January 2023. Pfizer Inc. develops, manufactures, and sells healthcare products worldwide. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York. PFIZER INC operates under Drug Manufacturers - Major classification in Germany and is traded on Frankfurt Stock Exchange. It employs 92400 people. To find out more about Pfizer Inc contact DVM DVM at 212 733 2323 or learn more at https://www.pfizer.com.

Pfizer Inc Investment Alerts

Pfizer Market Capitalization

The company currently falls under 'Mega-Cap' category with a current market capitalization of 212.98 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Pfizer's market, we take the total number of its shares issued and multiply it by Pfizer's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Pfizer Profitablity

The company has Profit Margin (PM) of 0.31 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.39 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.39.

Technical Drivers

As of the 28th of November, Pfizer holds the Coefficient Of Variation of (3,082), risk adjusted performance of (0.02), and Variance of 2.24. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Pfizer, as well as the relationship between them. Please check Pfizer Inc treynor ratio, value at risk, and the relationship between the information ratio and maximum drawdown to decide if Pfizer Inc is priced some-what accurately, providing market reflects its current price of 24.57 per share.

Pfizer Inc Price Movement Analysis

Pfizer Outstanding Bonds

Pfizer Predictive Daily Indicators

Pfizer Forecast Models

Pfizer's time-series forecasting models are one of many Pfizer's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Pfizer's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Pfizer prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Pfizer shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Pfizer. By using and applying Pfizer Stock analysis, traders can create a robust methodology for identifying Pfizer entry and exit points for their positions.

When running Pfizer's price analysis, check to measure Pfizer's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pfizer is operating at the current time. Most of Pfizer's value examination focuses on studying past and present price action to predict the probability of Pfizer's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pfizer's price. Additionally, you may evaluate how the addition of Pfizer to your portfolios can decrease your overall portfolio volatility.